Business
ASX to rise, Pfizer bolsters vaccine bets – The Australian Financial Review
Australian shares are poised to open lower after Wall Street shares sold off late in the session amid concerns surging virus cases will prompt wider lockdowns.
Pfizer and its partner BioNTech plan to submit the data to other regulatory agencies around the world and submit data from the study to a peer-reviewed scientific journal.
Pfizer reiterated that it expects to make as many as 50 million vaccine doses this year, enough to protect 25 million people, and then produce up to 1.3 billion doses in 2021.
“In my view, what stocks have not fully priced is more likely to be the 6+ month outlook that could benefit from expedited vaccine availability as opposed…
-
Noosa News22 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
Noosa News15 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General15 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Noosa News7 hours agoNew playground equipment encourages children to learn through ‘risky play’